Table 2.
Operative Characteristics and Receiver Outcomes in Laparoscopic Versus Transvaginal Nephrectomy Groups
| LLDNa (n = 70) |
TVNALDNa (n = 45) |
P Value | |||||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Median (Minimum-Maximum) | n (%) | Mean (SD) | Median (Minimum-Maximum) | n (%) | ||
| Transplantation | |||||||
| Warm ischemia (s) | 176.5 (61.3) | 165 (77–414) | 182.5 (38.9) | 177 (112–261) | .193 | ||
| Cold ischemia (min) | 42.0 (15.1) | 42 (19–91) | 41.1 (10.7) | 41.5 (24–69) | .965 | ||
| No. of arterial anastomoses | 1.2 (0.4) | 1 (1–2) | 1.2 (0.4) | 1 (1–2) | .342 | ||
| No. of venous anastomoses | 1.1 (0.4) | 1 (1–3) | 1.0 (0.0) | 1 (1–1) | .029 | ||
| Donor operation time (min) | 151.4 (25.2) | 150 (100–210) | 156.7 (30.4) | 150 (110–270) | .503 | ||
| Length of hospitalization (d) | 2.7 (0.4) | 2 (2–5) | 2.7 (0.5) | 2 (1–5) | .973 | ||
| VASa pain score at discharge (0–10) | 2 (0.5) | 2 (1–6) | 1.5 (0.5) | 1.5 (1–5) | .786 | ||
| Serum creatinine (mg/dL) | |||||||
| At discharge | 1.36 (0.50) | 1.31 (0.35–3.42) | 1.24 (0.54) | 1.22 (0.31–3.62) | .852 | ||
| 6 mo postoperatively | 1.49 (0.58) | 1.39 (0.41–3.03) | 1.40 (0.67) | 1.19 (0.72–3.25) | .159 | ||
| 12 mo postoperatively | 1.35 (0.41) | 1.34 (0.44–2.27) | 1.35 (0.63) | 1.12 (0.76–2.32) | .734 | ||
| Receiver outcome | |||||||
| Major complication | 1 (1.4) | 2 (4.4) | .560 | ||||
| Graft lossb | 2 (2.9) | 0 (0.0) | .519 | ||||
| Death | 2 (2.9) | 0 (0.0) | .519 | ||||
a
LLDN = laparoscopic living-donor nephrectomy; TVNALDN = transvaginal natural orifice transluminal endoscopic surgery–assisted living-donor nephrectomy; VAS = visual analog scale.
b
One of these patients has died and therefore is also listed in the “Death” category.